Clinical Trial

ONO-2017 Study Japanese Patients With Primary Generalized Tonic Clonic Seizures.

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
To investigate the efficacy and safety of ONO-2017 in combination with antiepileptics in Japanese epileptic patients with generalized tonic-clonic seizures.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-08-28; most recent amendment 2025-06-15.
Trial Details
NCT Number NCT06579573
Lead Sponsor Ono Pharmaceutical Co., Ltd.
Conditions Epilepsy, Generalized
Enrollment 15 participants
Start Date 2022-07-12
Primary Completion 2027-01-31 (estimated)
Study Completion 2027-01-31 (estimated)
Updated on ClinicalTrials.gov 2025-06-17